Physioneal 40 Glucose 3.86% w/v/38.6mg/ml Solution for peritoneal dialysis Malta - English - Medicines Authority

physioneal 40 glucose 3.86% w/v/38.6mg/ml solution for peritoneal dialysis

baxter healthcare limited - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride dihydrate 0.184 g/l; glucose monohydrate 42.5 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.38 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.68 g/l - blood substitutes and perfusion solutions

Physioneal 35 Glucose Clear-Flex 1.36%w/v/13.6mg/ml Malta - English - Medicines Authority

physioneal 35 glucose clear-flex 1.36%w/v/13.6mg/ml

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l; glucose monohydrate 20 g/l; magnesium chloride hexahydrate 0.068 g/l; sodium chloride 5.67 g/l; sodium hydrogen carbonate 9.29 g/l; sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Physioneal 35 Glucose Clear-Flex 2.27% w/v/22.7mg/ml Malta - English - Medicines Authority

physioneal 35 glucose clear-flex 2.27% w/v/22.7mg/ml

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l; glucose monohydrate 33.3 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 21.12 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Physioneal 35 Glucose Clear-Flex 3.86% w/v/38.6mg/ml Malta - English - Medicines Authority

physioneal 35 glucose clear-flex 3.86% w/v/38.6mg/ml

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.257 g/l; glucose monohydrate 42.5 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.67 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.12 g/l - blood substitutes and perfusion solutions

Physioneal 40 Glucose Clear-Flex 1.36%w/v /13.6mg/ml Malta - English - Medicines Authority

physioneal 40 glucose clear-flex 1.36%w/v /13.6mg/ml

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.184 g/l; glucose monohydrate 15 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.38 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.68 g/l - blood substitutes and perfusion solutions

Physioneal 40 Glucose Clear-Flex 2.27%w/v/22.7mg/ml Malta - English - Medicines Authority

physioneal 40 glucose clear-flex 2.27%w/v/22.7mg/ml

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.507 g/l; glucose monohydrate 68.85 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 8.43 g/l; sodium hydrogen carbonate 3.29 g/l; sodium lactate 1.68 g/l - blood substitutes and perfusion solutions

Physioneal 40 Glucose Clear-Flex 3.86%w/v /38.6mg/ml Malta - English - Medicines Authority

physioneal 40 glucose clear-flex 3.86%w/v /38.6mg/ml

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.184 g/l; glucose monohydrate 42.5 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.38 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.68 g/l - blood substitutes and perfusion solutions

zegerid with magnesium hydroxide- omeprazole, sodium bicarbonate and magnesium hydroxide tablet, chewable United States - English - NLM (National Library of Medicine)

zegerid with magnesium hydroxide- omeprazole, sodium bicarbonate and magnesium hydroxide tablet, chewable

santarus, inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9), sodium bicarbonate (unii: 8mdf5v39qo) (sodium bicarbonate - unii:8mdf5v39qo), magnesium hydroxide (unii: nbz3qy004s) (magnesium hydroxide - unii:nbz3qy004s) - tablet, chewable - 20 mg - zegerid with magnesium hydroxide is indicated for short-term treatment of active duodenal ulcer. most patients heal within four weeks. some patients may require an additional four weeks of therapy. zegerid with magnesium hydroxide is indicated for short-term treatment (4-8 weeks) of active benign gastric ulcer. (see clinical pharmacology, clinical studies, gastric ulcer.) zegerid with magnesium hydroxide is indicated for the treatment of heartburn and other symptoms associated with gerd. zegerid with magnesium hydroxide is indicated for the short-term treatment (4-8 weeks) of erosive esophagitis which has been diagnosed by endoscopy. (see clinical pharmacology, clinical studies.) the efficacy of zegerid with magnesium hydroxide used for longer than 8 weeks in these patients has not been established. in the rare instance of a patient not responding to 8 weeks of treatment, it may be helpful to give up to an additional 4 weeks of treatment. if there is recurrence of erosive esophagitis or gerd symptoms (eg, hea

FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

fosrenol lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle

takeda pharmaceuticals australia pty ltd - lanthanum carbonate hydrate, quantity: 1431 mg - tablet, chewable - excipient ingredients: dextrates; magnesium stearate; silicon dioxide - treatment of hyperphosphataemia in adults with chronic renal failure on haemodialysis or continuous ambulatory peritoneal dialysis (capd).

Plasma-Lyte 148 (ph 7.4) Solution for Infusion N/A Malta - English - Medicines Authority

plasma-lyte 148 (ph 7.4) solution for infusion n/a

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions